Predictive oncology stock.

Nov 30, 2023 · Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ...

Predictive oncology stock. Things To Know About Predictive oncology stock.

Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.95 and traded ...Predictive Oncology's common stock will continue to be traded on the Nasdaq Capital Market under the symbol POAI and will begin trading on a split-adjusted ...Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Pfizer (PFE) Pfizer (NYSE:PFE) remains one of the more polarizing stocks in the biotech sector. And unfortunately for investors, it’s also one of the most beaten-down stocks. Since closing at an ...

Nov 13, 2023 · Get Predictive Oncology Inc (POAI.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments २०२३ मार्च १३ ... $POAI - Predictive Oncology - Extremely Undervalued Growth/AI Biotech Stock? DD. I've recently been looking into various stocks in the oncology ...

Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022View the latest Predictive Oncology Inc. (POAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.95 and traded ...Leading-edge solution. Predictive Oncology has launched a breakthrough solution at a pivotal time in drug discovery that enables pharmaceutical and biotech companies to expedite drug development and speed time to market. The company’s novel platform technology valued at $400M+ has the power to impact a billion-dollar biopharmaceutical ...Predictive Oncology Pharmaceutical Manufacturing Pittsburgh, PA 1,638 followers Predictive Oncology (NASDAQ:POAI) offers a suite of solutions for oncology drug development from discovery to trials.Predictive Oncology CEO Raymond Vennare and Cvergenx CEO Javier Torres-Roca join Natalie Stoberman to share news of their new partnership to develop the first-ever genomics-based approach to precis...The Predictive Oncology Inc ( POAI) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $5.0628, representing a +68.20% increase from the current price of $3.01. The highest analyst price target is $9.9664, and the lowest is $0.1593. Based on our technical indicators, the current sentiment ...

Mar 16, 2023 · The shares of Series F Preferred Stock will be distributed to such recipients a. EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology ...

Find real-time ONPH - Oncology Pharma Inc stock quotes, company profile, news and forecasts from CNN Business.

Predictive Oncology Inc. (POAI) Stock Price | Stock Quote Nasdaq - MarketScreener PREDICTIVE ONCOLOGY INC. Predictive Oncology Inc. Stock price …FOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company …Institutional investors purchased a net $136.9 thousand shares of POAI during the quarter ended March 2019, and now own 9.41% of the total float, a percentage ...Predictive Oncology recorded revenue of $715,056 in the third quarter of 2023, compared to $455,827 for the comparable period in 2022. The increase in revenues related primarily to higher sales of ...Get a real-time Predictive Oncology Inc. (POAI) stock price quote with breaking news, financials, statistics, charts and more.Apr 20, 2023 · Predictive Oncology’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol POAI and will begin trading on a split-adjusted basis when the market opens on Monday ... Nov 29, 2023 · The Predictive Oncology Inc stock price gained 2.03% on the last trading day (Friday, 24th Nov 2023), rising from $2.95 to $3.01. During the last trading day the stock fluctuated 6.77% from a day low at $2.84 to a day high of $3.03. The price has fallen in 7 of the last 10 days and is down by -10.68% for this period.

Find the latest Predictive Oncology Inc. (POAI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Nov 27, 2023 · The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ... Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Big data and predictive analytics have immense potential to improve risk stratification, particularly in data-rich fields like oncology. This article reviews the literature published on use cases and challenges in applying predictive analytics to improve risk stratification in oncology. We characterized evidence-based use cases of predictive …

The estimated Net Worth of Robert L Myers is at least $346 mil dollars as of 25 September 2023. Mr Myers owns over 1,667 units of Predictive Oncology stock worth over $18,305 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …

Predictive Oncology Inc. Common Stock (POAI) Stock Price, Quote, News & History | Nasdaq MY QUOTES: POAI Edit my quotes Predictive Oncology Inc. Common Stock (POAI) 0 Add to...Predictive Oncology Inc stock performance at a glance. Check Predictive Oncology Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Against this backdrop, HLGN stock has carved out a place on watch lists this week. Predictive Oncology Inc. (POAI) There is no shortage of excitement around AI stocks. Thanks to the popularity of ChatGPT, there’s been a surge of interest in any company with exposure to the industry.When is Predictive Oncology's earnings date? Predictive Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 19th, 2024 based off last year's report dates. Learn more on POAI's earnings history.The estimated Net Worth of Robert L Myers is at least $346 mil dollars as of 25 September 2023. Mr Myers owns over 1,667 units of Predictive Oncology stock worth over $18,305 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.The estimated Net Worth of J Melville Engle is at least $103 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $99,663 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comTrack Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Institutional investors purchased a net $136.9 thousand shares of POAI during the quarter ended March 2019, and now own 9.41% of the total float, a percentage ...5. VanEck Biotech ETF. Total assets: $517 million. Expense ratio: 0.35%. Dividend yield: 0.35%. The VanEck Biotech ETF ( BBH 0.9%) tries to own the most liquid biotech companies based on market ...

Feb 24, 2021 · Predictive Oncology includes various subsidiaries in the drug development and formulation space, as well as a legacy medical device business generating revenues, but this article focuses on their ...

The estimated Net Worth of Robert L Myers is at least $351 ezer dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $23,211 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.

Nov 29, 2023 · The Predictive Oncology Inc stock price gained 2.03% on the last trading day (Friday, 24th Nov 2023), rising from $2.95 to $3.01. During the last trading day the stock fluctuated 6.77% from a day low at $2.84 to a day high of $3.03. The price has fallen in 7 of the last 10 days and is down by -10.68% for this period. Leading-edge solution. Predictive Oncology has launched a breakthrough solution at a pivotal time in drug discovery that enables pharmaceutical and biotech companies to expedite drug development and speed time to market. The company’s novel platform technology valued at $400M+ has the power to impact a billion-dollar biopharmaceutical ...Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing.ETFs positionnés sur Predictive Oncology Inc. Nom, Poids, Encours, Varia. 1 janv. Note Invest. VANGUARD TOTAL STOCK MARKET ...Predictive Oncology (NASDAQ: POAI) is an early-stage AI pharma stock with a differentiated business model.The company owns a biorepository of tumor samples, a lab and a good manufacturing practice ...What's Happening with POAI Stock Today. Predictive Oncology Inc (POAI) stock has risen 1.56% while the S&P 500 has fallen -0.05% as of 10:07 AM on Thursday, Jun 22. POAI has risen $0.06 from the previous closing price of $3.83 on volume of 25,176 shares. Over the past year the S&P 500 is higher by 16.05% while POAI has fallen -50.82%.Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...Admittedly, Gilead is starting from scratch in oncology, with only three approved products - for context, Bristol Myers Squibb markets and sells 9 major oncology products, which will likely drive ...Nov 30, 2023 · Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence. EAGAN, Minn., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) and Cvergenx, Inc. today announced an agreement to form a strategic ... EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused …12 brokers have issued 12-month price objectives for Rain Oncology's stock. Their RAIN share price targets range from $11.00 to $24.00. On average, they anticipate the company's stock price to reach $17.00 in the next year. This suggests a possible upside of 1,431.5% from the stock's current price.

EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today …Predictive Oncology. POAI. $3.09 ... as of November 29 4:00:00 PM EST. Predictive Oncology (POAI) Stock Price Performance. Predictive Oncology (POAI) Stock Key Data. Summary Additional Data ...Nov 30, 2023 · Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ... Instagram:https://instagram. dh horton buildersbest stock under 10 dollarstreasury 6 monthmortgage loans for low income single mothers Get the latest Predictive Oncology Inc (POAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. gphofmicrocap stocks The estimated Net Worth of Robert L Myers is at least $346 Thousand dollars as of 25 September 2023. Mr Myers owns over 1,667 units of Predictive Oncology stock worth over $18,305 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology. manchester united share price POAI 2HR test Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Helomics, Skyline, Soluble, and test Predictive Oncology, Inc. engages in …Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …